ALMS

ALUMIS INC.CIK 1847367 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

$21.45M

8 trades · 1 insiders

Open-mkt sales · 90d

$2.03M

4 trades · 1 insiders

Net · 90d

$19.42M

Insiders on file

AI insights for ALMS PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for ALMS

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
AKKARAJU SRINIVAS	Director	39	$67.00M	$2.03M	2026-09-08
Pangali Sanam	Chief Legal Officer	9	$0	$211.9K	2026-08-03
Bradley Mark Christopher	Chief Development Officer	27	$0	$135.6K	2026-08-03
Drappa Jorn	Chief Medical Officer	27	$0	$129.1K	2026-08-03
Goldstein David M	Chief Scientific Officer	22	$0	$136.9K	2026-08-03
Schroer John R.	Chief Financial Officer	23	$0	$173.1K	2026-08-03
Hardiman Roy C.	Chief Business & Strategy Ofcr	22	$0	$142.0K	2026-08-03
TETRAULT LYNN A.	Director	3	$0	$0	2026-06-30
Srivastava Sapna	Director	8	$0	$0	2026-06-30
Yao Zhengbin	Director	10	$0	$0	2026-06-30
Machado Patrick	Director	12	$0	$0	2026-06-30
Foresite Labs Affiliates 2021, LLC	10% Owner	43	$43.83M	$0	2026-04-01
Foresite Capital Management VI LLC	10% Owner	8	$3.09M	$0	2026-04-01
Tananbaum James B.	Director, 10% Owner	45	$50.83M	$0	2026-04-01
Babler Martin	President, CEO and Chairman	26	$100.8K	$0	2026-01-26
Foresite Labs, LLC	10% Owner	2	$7.00M	$0	2026-01-08
Foresite Labs Fund I, L.P.	10% Owner	3	$7.53M	$0	2026-01-08
Richardson Derrick	SVP, People and Culture	22	$0	$0	2025-07-29
AyurMaya Capital Management Company, LP	Director, 10% Owner	1	$0	$0	2025-05-21
Foresite Labs Management I, LLC	10% Owner	2	$202.3K	$0	2025-05-06
Colowick Alan	Director	2	$129.5K	$0	2025-04-02
Klein Sara	General Counsel - Corp Secy	18	$0	$0	2025-02-18
Foresite Capital Opportunity Management V, LLC	10% Owner	32	$40.00M	$0	2024-07-01

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
AKKARAJU SRINIVAS	Director	S Sale	2026-09-08	2026-09-09	48,065	$10.55	$507.1K	2,025,493	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2026-09-08	2026-09-09	273,290	$10.63	$2.91M	2,298,783	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2026-09-08	2026-09-09	273,291	$10.63	$2.91M	4,937,026	SEC↗
AKKARAJU SRINIVAS	Director	S Sale	2026-09-08	2026-09-09	48,066	$10.55	$507.1K	4,663,735	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2026-09-08	2026-09-09	273,290	$10.63	$2.90M	2,298,783	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2026-09-08	2026-09-09	273,291	$10.63	$2.90M	4,937,026	SEC↗
AKKARAJU SRINIVAS	Director	S Sale	2026-09-08	2026-09-09	48,065	$10.55	$507.0K	2,025,493	SEC↗
AKKARAJU SRINIVAS	Director	S Sale	2026-09-08	2026-09-09	48,066	$10.55	$507.0K	4,663,735	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2026-09-04	2026-09-09	220,070	$11.17	$2.46M	4,711,801	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2026-09-04	2026-09-09	220,070	$11.17	$2.46M	2,073,558	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2026-09-04	2026-09-09	220,070	$11.17	$2.46M	2,073,558	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2026-09-04	2026-09-09	220,070	$11.17	$2.46M	4,711,801	SEC↗
Bradley Mark Christopher	Chief Development Officer	S Sale	2026-08-03	2026-08-05	2,572	$26.37	$67.8K	48,533	SEC↗
Drappa Jorn	Chief Medical Officer	S Sale	2026-08-03	2026-08-05	2,447	$26.37	$64.5K	56,892	SEC↗
Goldstein David M	Chief Scientific Officer	S Sale	2026-08-03	2026-08-05	2,596	$26.37	$68.5K	30,970	SEC↗
Hardiman Roy C.	Chief Business & Strategy Of	S Sale	2026-08-03	2026-08-05	2,692	$26.37	$71.0K	207,746	SEC↗
Pangali Sanam	Chief Legal Officer	S Sale	2026-08-03	2026-08-05	1,364	$26.37	$36.0K	9,747	SEC↗
Schroer John R.	Chief Financial Officer	S Sale	2026-08-03	2026-08-05	3,282	$26.37	$86.5K	24,718	SEC↗
Pangali Sanam	Chief Legal Officer	S Sale	2026-08-03	2026-08-05	1,364	$26.37	$36.0K	9,747	SEC↗
Bradley Mark Christopher	Chief Development Officer	S Sale	2026-08-03	2026-08-05	2,572	$26.37	$67.8K	48,533	SEC↗
Drappa Jorn	Chief Medical Officer	S Sale	2026-08-03	2026-08-05	2,447	$26.37	$64.5K	56,892	SEC↗
Goldstein David M	Chief Scientific Officer	S Sale	2026-08-03	2026-08-05	2,596	$26.37	$68.5K	30,970	SEC↗
Schroer John R.	Chief Financial Officer	S Sale	2026-08-03	2026-08-05	3,282	$26.37	$86.5K	24,718	SEC↗
Hardiman Roy C.	Chief Business & Strategy Of	S Sale	2026-08-03	2026-08-05	2,692	$26.37	$71.0K	207,746	SEC↗
Pangali Sanam	Chief Legal Officer	M Exercise deriv	2026-07-06	2026-07-08	5,000	—	$0	36,000	SEC↗
Pangali Sanam	Chief Legal Officer	S Sale	2026-07-06	2026-07-08	5,000	$28.00	$140.0K	11,111	SEC↗
Pangali Sanam	Chief Legal Officer	M Exercise	2026-07-06	2026-07-08	5,000	$5.06	$25.3K	16,111	SEC↗
AKKARAJU SRINIVAS	Director	A Award deriv	2026-06-30	2026-07-02	15,528	—	$0	15,528	SEC↗
Machado Patrick	Director	A Award deriv	2026-06-30	2026-07-02	15,528	—	$0	15,528	SEC↗
Srivastava Sapna	Director	A Award deriv	2026-06-30	2026-07-02	15,528	—	$0	15,528	SEC↗
Yao Zhengbin	Director	A Award deriv	2026-06-30	2026-07-02	15,528	—	$0	15,528	SEC↗
TETRAULT LYNN A.	Director	A Award deriv	2026-06-30	2026-07-02	15,528	—	$0	15,528	SEC↗
AKKARAJU SRINIVAS	Director	A Award	2026-06-30	2026-07-02	3,553	—	$0	3,553	SEC↗
Machado Patrick	Director	A Award	2026-06-30	2026-07-02	3,553	—	$0	3,553	SEC↗
Srivastava Sapna	Director	A Award	2026-06-30	2026-07-02	3,553	—	$0	3,553	SEC↗
Yao Zhengbin	Director	A Award	2026-06-30	2026-07-02	3,553	—	$0	27,082	SEC↗
TETRAULT LYNN A.	Director	A Award	2026-06-30	2026-07-02	3,553	—	$0	3,553	SEC↗
Drappa Jorn	Chief Medical Officer	M Exercise deriv	2026-05-22	2026-05-27	11,317	—	$0	159,805	SEC↗
Drappa Jorn	Chief Medical Officer	M Exercise deriv	2026-05-22	2026-05-27	15,535	—	$0	164,465	SEC↗
Drappa Jorn	Chief Medical Officer	M Exercise	2026-05-22	2026-05-27	11,317	$8.84	$100.0K	43,804	SEC↗
Drappa Jorn	Chief Medical Officer	M Exercise	2026-05-22	2026-05-27	15,535	$5.06	$78.6K	59,339	SEC↗
Tananbaum James B.	Director, 10% Owner	J Other	2026-04-01	2026-04-03	1,123,337	—	$0	1,123,337	SEC↗
Tananbaum James B.	Director, 10% Owner	J Other	2026-04-01	2026-04-03	1,176,470	—	$0	0	SEC↗
Tananbaum James B.	Director, 10% Owner	J Other	2026-04-01	2026-04-03	1,123,337	—	$0	0	SEC↗
Tananbaum James B.	Director, 10% Owner	J Other	2026-04-01	2026-04-03	680,486	—	$0	680,486	SEC↗
Foresite Capital Management VI	10% Owner	J Other	2026-04-01	2026-04-03	1,123,337	—	$0	1,123,337	SEC↗
Foresite Capital Management VI	10% Owner	J Other	2026-04-01	2026-04-03	680,486	—	$0	680,486	SEC↗
Foresite Capital Management VI	10% Owner	J Other	2026-04-01	2026-04-03	1,123,337	—	$0	0	SEC↗
Foresite Capital Management VI	10% Owner	J Other	2026-04-01	2026-04-03	1,176,470	—	$0	0	SEC↗
Foresite Labs Affiliates 2021,	10% Owner	J Other	2026-04-01	2026-04-03	1,123,337	—	$0	0	SEC↗
Foresite Labs Affiliates 2021,	10% Owner	J Other	2026-04-01	2026-04-03	1,176,470	—	$0	0	SEC↗
Foresite Labs Affiliates 2021,	10% Owner	J Other	2026-04-01	2026-04-03	680,486	—	$0	680,486	SEC↗
Foresite Labs Affiliates 2021,	10% Owner	J Other	2026-04-01	2026-04-03	1,123,337	—	$0	1,123,337	SEC↗
Goldstein David M	Chief Scientific Officer	A Award deriv	2026-01-26	2026-01-28	216,675	—	$0	216,675	SEC↗
Schroer John R.	Chief Financial Officer	A Award deriv	2026-01-26	2026-01-28	202,225	—	$0	202,225	SEC↗
Drappa Jorn	Chief Medical Officer	A Award deriv	2026-01-26	2026-01-28	221,450	—	$0	221,450	SEC↗
Bradley Mark Christopher	Chief Development Officer	A Award deriv	2026-01-26	2026-01-28	190,225	—	$0	190,225	SEC↗
Hardiman Roy C.	Chief Business & Strategy Of	A Award deriv	2026-01-26	2026-01-28	190,875	—	$0	190,875	SEC↗
Babler Martin	President, CEO and Chairman	A Award deriv	2026-01-26	2026-01-28	745,875	—	$0	745,875	SEC↗
Pangali Sanam	Chief Legal Officer	A Award deriv	2026-01-26	2026-01-28	186,200	—	$0	186,200	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2026-01-09	2026-01-13	588,235	$17.00	$10.00M	1,853,488	SEC↗
Tananbaum James B.	Director, 10% Owner	P Buy	2026-01-08	2026-01-12	117,647	$17.00	$2.00M	5,702,536	SEC↗
Tananbaum James B.	Director, 10% Owner	P Buy	2026-01-08	2026-01-12	294,117	$17.00	$5.00M	2,908,332	SEC↗
Foresite Labs Fund I, L.P.	10% Owner	P Buy	2026-01-08	2026-01-12	294,117	$17.00	$5.00M	2,908,332	SEC↗
Foresite Labs Fund I, L.P.	10% Owner	P Buy	2026-01-08	2026-01-12	117,647	$17.00	$2.00M	5,702,536	SEC↗
Foresite Labs, LLC	10% Owner	P Buy	2026-01-08	2026-01-12	294,117	$17.00	$5.00M	2,908,332	SEC↗
Foresite Labs, LLC	10% Owner	P Buy	2026-01-08	2026-01-12	117,647	$17.00	$2.00M	5,702,536	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-12-05	2025-12-09	64,969	$8.95	$581.5K	1,143,845	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-12-05	2025-12-09	51,380	$10.73	$551.3K	1,265,253	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-12-05	2025-12-09	70,028	$10.01	$701.0K	1,213,873	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-12-04	2025-12-04	66,027	$8.18	$540.1K	1,078,876	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-12-03	2025-12-04	100,000	$7.75	$775.0K	1,012,849	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-12-02	2025-12-04	96,000	$7.55	$724.8K	912,849	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-12-01	2025-12-01	86,350	$7.46	$644.2K	816,849	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-11-28	2025-12-01	38,702	$7.64	$295.7K	730,499	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-11-26	2025-12-01	48,537	$7.64	$370.8K	691,797	SEC↗
Foresite Labs Affiliates 2021,	10% Owner	P Buy	2025-11-21	2025-11-25	72,212	$7.38	$532.9K	2,614,215	SEC↗
Tananbaum James B.	Director, 10% Owner	P Buy	2025-11-21	2025-11-25	72,212	$7.38	$532.9K	2,614,215	SEC↗
Foresite Labs Fund I, L.P.	10% Owner	P Buy	2025-11-21	2025-11-25	72,212	$7.38	$532.9K	2,614,215	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-11-20	2025-11-24	125,743	$7.20	$905.3K	643,260	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-11-19	2025-11-19	137,772	$6.56	$903.8K	517,517	SEC↗
Tananbaum James B.	Director, 10% Owner	P Buy	2025-11-19	2025-11-19	190,500	$6.56	$1.25M	2,542,003	SEC↗
Foresite Capital Management VI	10% Owner	P Buy	2025-11-19	2025-11-19	190,500	$6.56	$1.25M	2,542,003	SEC↗
Foresite Labs Affiliates 2021,	10% Owner	P Buy	2025-11-19	2025-11-19	190,500	$6.56	$1.25M	2,542,003	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-11-18	2025-11-19	102,652	$6.05	$621.0K	379,745	SEC↗
Tananbaum James B.	Director, 10% Owner	P Buy	2025-11-18	2025-11-19	117,374	$6.19	$726.5K	2,351,503	SEC↗
Foresite Capital Management VI	10% Owner	P Buy	2025-11-18	2025-11-19	117,374	$6.19	$726.5K	2,351,503	SEC↗
Foresite Labs Affiliates 2021,	10% Owner	P Buy	2025-11-18	2025-11-19	117,374	$6.19	$726.5K	2,351,503	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-11-17	2025-11-19	914	$5.51	$5.0K	277,093	SEC↗
Tananbaum James B.	Director, 10% Owner	P Buy	2025-11-17	2025-11-19	50,000	$5.60	$280.0K	2,084,129	SEC↗
Tananbaum James B.	Director, 10% Owner	P Buy	2025-11-17	2025-11-19	150,000	$5.59	$838.5K	2,234,129	SEC↗
Foresite Capital Management VI	10% Owner	P Buy	2025-11-17	2025-11-19	150,000	$5.59	$838.5K	2,234,129	SEC↗
Foresite Capital Management VI	10% Owner	P Buy	2025-11-17	2025-11-19	50,000	$5.60	$280.0K	2,084,129	SEC↗
Foresite Labs Affiliates 2021,	10% Owner	P Buy	2025-11-17	2025-11-19	150,000	$5.59	$838.5K	2,234,129	SEC↗
Foresite Labs Affiliates 2021,	10% Owner	P Buy	2025-11-17	2025-11-19	50,000	$5.60	$280.0K	2,084,129	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-11-13	2025-11-17	276,179	$5.25	$1.45M	276,179	SEC↗
AKKARAJU SRINIVAS	Director	A Award deriv	2025-07-30	2025-08-01	49,800	—	$0	49,800	SEC↗
Machado Patrick	Director	A Award deriv	2025-07-30	2025-08-01	49,800	—	$0	49,800	SEC↗
Srivastava Sapna	Director	A Award deriv	2025-07-30	2025-08-01	49,800	—	$0	49,800	SEC↗
Yao Zhengbin	Director	A Award deriv	2025-07-30	2025-08-01	49,800	—	$0	49,800	SEC↗
TETRAULT LYNN A.	Director	A Award deriv	2025-07-30	2025-08-01	49,800	—	$0	49,800	SEC↗
Babler Martin	President, CEO and Chairman	A Award deriv	2025-07-29	2025-07-31	662,000	—	$0	662,000	SEC↗
Babler Martin	President, CEO and Chairman	A Award deriv	2025-07-29	2025-07-31	150,000	—	$0	150,000	SEC↗
Bradley Mark Christopher	Chief Development Officer	A Award deriv	2025-07-29	2025-07-31	107,100	—	$0	107,100	SEC↗
Drappa Jorn	Chief Medical Officer	A Award deriv	2025-07-29	2025-07-31	101,850	—	$0	101,850	SEC↗
Goldstein David M	Chief Scientific Officer	A Award deriv	2025-07-29	2025-07-31	107,950	—	$0	107,950	SEC↗
Hardiman Roy C.	Chief Business & Strategy Of	A Award deriv	2025-07-29	2025-07-31	111,950	—	$0	111,950	SEC↗
Schroer John R.	Chief Financial Officer	A Award deriv	2025-07-29	2025-07-31	111,950	—	$0	111,950	SEC↗
Richardson Derrick	SVP, People and Culture	A Award deriv	2025-07-29	2025-07-31	64,200	—	$0	64,200	SEC↗
Pangali Sanam	Chief Legal Officer	A Award deriv	2025-07-29	2025-07-31	40,000	—	$0	40,000	SEC↗
Bradley Mark Christopher	Chief Development Officer	A Award	2025-07-29	2025-07-31	26,750	—	$0	48,728	SEC↗
Drappa Jorn	Chief Medical Officer	A Award	2025-07-29	2025-07-31	25,450	—	$0	28,450	SEC↗
Goldstein David M	Chief Scientific Officer	A Award	2025-07-29	2025-07-31	27,000	—	$0	29,115	SEC↗
Hardiman Roy C.	Chief Business & Strategy Of	A Award	2025-07-29	2025-07-31	28,000	—	$0	206,401	SEC↗
Schroer John R.	Chief Financial Officer	A Award	2025-07-29	2025-07-31	28,000	—	$0	28,000	SEC↗
Richardson Derrick	SVP, People and Culture	A Award	2025-07-29	2025-07-31	42,800	—	$0	42,800	SEC↗
Pangali Sanam	Chief Legal Officer	A Award	2025-07-29	2025-07-31	10,000	—	$0	11,111	SEC↗
Pangali Sanam	Chief Legal Officer	A Award deriv	2025-07-10	2025-07-14	100,000	—	$0	100,000	SEC↗
Machado Patrick	Director	A Award deriv	2025-05-21	2025-05-23	44,364	—	$0	44,364	SEC↗
Machado Patrick	Director	A Award deriv	2025-05-21	2025-05-23	19,528	—	$0	19,528	SEC↗
Machado Patrick	Director	A Award deriv	2025-05-21	2025-05-23	13,804	—	$0	13,804	SEC↗
Machado Patrick	Director	A Award deriv	2025-05-21	2025-05-23	41,499	—	$0	41,499	SEC↗
Machado Patrick	Director	A Award deriv	2025-05-21	2025-05-23	11,189	—	$0	11,189	SEC↗
Machado Patrick	Director	A Award	2025-05-21	2025-05-23	7,064	—	$0	7,064	SEC↗
AyurMaya Capital Management Co	Director, 10% Owner	A Award	2025-05-21	2025-05-23	4,493,741	—	$0	15,139,707	SEC↗
AKKARAJU SRINIVAS	Director	A Award	2025-05-21	2025-05-23	1,214,582	—	$0	4,801,370	SEC↗
Foresite Labs Management I, LL	10% Owner	P Buy	2025-05-06	2025-05-06	20,000	$4.34	$86.8K	4,247,670	SEC↗
Foresite Labs Affiliates 2021,	10% Owner	P Buy	2025-05-06	2025-05-06	20,000	$4.34	$86.8K	4,247,670	SEC↗
Tananbaum James B.	Director, 10% Owner	P Buy	2025-05-06	2025-05-06	20,000	$4.34	$86.8K	4,247,670	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-05-05	2025-05-06	138,368	$4.58	$633.7K	3,564,786	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-05-05	2025-05-06	22,002	$5.27	$116.0K	3,586,788	SEC↗
AKKARAJU SRINIVAS	Director	P Buy	2025-05-02	2025-05-06	159,920	$4.55	$727.6K	3,426,418	SEC↗
Foresite Labs Management I, LL	10% Owner	P Buy	2025-05-02	2025-05-06	25,000	$4.62	$115.5K	4,227,670	SEC↗
Foresite Labs Affiliates 2021,	10% Owner	P Buy	2025-05-02	2025-05-06	25,000	$4.62	$115.5K	4,227,670	SEC↗
Tananbaum James B.	Director, 10% Owner	P Buy	2025-05-02	2025-05-06	25,000	$4.62	$115.5K	4,227,670	SEC↗
Colowick Alan	Director	P Buy	2025-04-02	2025-04-03	2,300	$7.49	$17.2K	18,404	SEC↗
Babler Martin	President, CEO and Chairman	P Buy	2025-04-01	2025-04-03	15,650	$6.44	$100.8K	106,454	SEC↗
Colowick Alan	Director	P Buy	2025-04-01	2025-04-03	16,104	$6.97	$112.2K	16,104	SEC↗
Babler Martin	President, CEO and Chairman	A Award deriv	2025-02-18	2025-02-20	523,000	—	$0	523,000	SEC↗
Goldstein David M	Chief Scientific Officer	A Award deriv	2025-02-18	2025-02-20	180,000	—	$0	180,000	SEC↗
Drappa Jorn	Chief Medical Officer	A Award deriv	2025-02-18	2025-02-20	180,000	—	$0	180,000	SEC↗
Klein Sara	Chief Legal Officer	A Award deriv	2025-02-18	2025-02-20	180,000	—	$0	180,000	SEC↗
Bradley Mark Christopher	Chief Development Officer	A Award deriv	2025-02-18	2025-02-20	140,000	—	$0	140,000	SEC↗
Schroer John R.	Chief Financial Officer	A Award deriv	2025-02-18	2025-02-20	140,000	—	$0	140,000	SEC↗
Richardson Derrick	SVP, People and Culture	A Award deriv	2025-02-18	2025-02-20	50,000	—	$0	50,000	SEC↗
Hardiman Roy C.	Chief Business & Strategy Of	A Award deriv	2025-02-18	2025-02-20	140,000	—	$0	140,000	SEC↗
Babler Martin	President, CEO and Chairman	A Award deriv	2024-07-01	2024-07-01	245,989	—	$0	245,989	SEC↗
Babler Martin	President, CEO and Chairman	D To issuer deriv	2024-07-01	2024-07-01	478,288	—	$0	0	SEC↗
Babler Martin	President, CEO and Chairman	A Award deriv	2024-07-01	2024-07-01	241,210	—	$0	241,210	SEC↗
Babler Martin	President, CEO and Chairman	D To issuer deriv	2024-07-01	2024-07-01	241,210	—	$0	0	SEC↗
Babler Martin	President, CEO and Chairman	A Award deriv	2024-07-01	2024-07-01	107,028	—	$0	107,028	SEC↗
Babler Martin	President, CEO and Chairman	D To issuer deriv	2024-07-01	2024-07-01	107,028	—	$0	0	SEC↗
Babler Martin	President, CEO and Chairman	A Award deriv	2024-07-01	2024-07-01	263,101	—	$0	263,101	SEC↗
Babler Martin	President, CEO and Chairman	D To issuer deriv	2024-07-01	2024-07-01	263,101	—	$0	0	SEC↗
Babler Martin	President, CEO and Chairman	A Award deriv	2024-07-01	2024-07-01	534,759	—	$0	534,759	SEC↗
Babler Martin	President, CEO and Chairman	D To issuer deriv	2024-07-01	2024-07-01	534,759	—	$0	0	SEC↗
Babler Martin	President, CEO and Chairman	A Award deriv	2024-07-01	2024-07-01	106,951	—	$0	106,951	SEC↗
Babler Martin	President, CEO and Chairman	D To issuer deriv	2024-07-01	2024-07-01	106,951	—	$0	0	SEC↗
Babler Martin	President, CEO and Chairman	A Award deriv	2024-07-01	2024-07-01	380,852	—	$0	380,852	SEC↗
Babler Martin	President, CEO and Chairman	D To issuer deriv	2024-07-01	2024-07-01	380,852	—	$0	0	SEC↗
Babler Martin	President, CEO and Chairman	A Award deriv	2024-07-01	2024-07-01	21,390	—	$0	21,390	SEC↗
Babler Martin	President, CEO and Chairman	D To issuer deriv	2024-07-01	2024-07-01	21,390	—	$0	0	SEC↗
Babler Martin	President, CEO and Chairman	A Award deriv	2024-07-01	2024-07-01	478,288	—	$0	478,288	SEC↗
Babler Martin	President, CEO and Chairman	D To issuer deriv	2024-07-01	2024-07-01	245,989	—	$0	0	SEC↗
Bradley Mark Christopher	Chief Development Officer	D To issuer deriv	2024-07-01	2024-07-01	53,475	—	$0	0	SEC↗
Bradley Mark Christopher	Chief Development Officer	A Award deriv	2024-07-01	2024-07-01	155,304	—	$0	155,304	SEC↗
Bradley Mark Christopher	Chief Development Officer	D To issuer deriv	2024-07-01	2024-07-01	155,304	—	$0	0	SEC↗
Bradley Mark Christopher	Chief Development Officer	A Award deriv	2024-07-01	2024-07-01	23,093	—	$0	23,093	SEC↗
Bradley Mark Christopher	Chief Development Officer	D To issuer deriv	2024-07-01	2024-07-01	23,093	—	$0	0	SEC↗
Bradley Mark Christopher	Chief Development Officer	A Award deriv	2024-07-01	2024-07-01	12,834	—	$0	12,834	SEC↗
Bradley Mark Christopher	Chief Development Officer	D To issuer deriv	2024-07-01	2024-07-01	12,834	—	$0	0	SEC↗
Bradley Mark Christopher	Chief Development Officer	A Award deriv	2024-07-01	2024-07-01	128,342	—	$0	128,342	SEC↗
Bradley Mark Christopher	Chief Development Officer	D To issuer deriv	2024-07-01	2024-07-01	128,342	—	$0	0	SEC↗
Bradley Mark Christopher	Chief Development Officer	A Award deriv	2024-07-01	2024-07-01	130,481	—	$0	130,481	SEC↗
Bradley Mark Christopher	Chief Development Officer	D To issuer deriv	2024-07-01	2024-07-01	130,481	—	$0	0	SEC↗
Bradley Mark Christopher	Chief Development Officer	A Award deriv	2024-07-01	2024-07-01	4,278	—	$0	4,278	SEC↗
Bradley Mark Christopher	Chief Development Officer	D To issuer deriv	2024-07-01	2024-07-01	4,278	—	$0	0	SEC↗
Bradley Mark Christopher	Chief Development Officer	A Award deriv	2024-07-01	2024-07-01	53,475	—	$0	53,475	SEC↗
Drappa Jorn	Chief Medical Officer	D To issuer deriv	2024-07-01	2024-07-01	70,802	—	$0	0	SEC↗
Drappa Jorn	Chief Medical Officer	A Award deriv	2024-07-01	2024-07-01	54,545	—	$0	54,545	SEC↗
Drappa Jorn	Chief Medical Officer	D To issuer deriv	2024-07-01	2024-07-01	54,545	—	$0	0	SEC↗
Drappa Jorn	Chief Medical Officer	A Award deriv	2024-07-01	2024-07-01	18,652	—	$0	18,652	SEC↗
Drappa Jorn	Chief Medical Officer	D To issuer deriv	2024-07-01	2024-07-01	18,652	—	$0	0	SEC↗
Drappa Jorn	Chief Medical Officer	A Award deriv	2024-07-01	2024-07-01	12,834	—	$0	12,834	SEC↗
Drappa Jorn	Chief Medical Officer	D To issuer deriv	2024-07-01	2024-07-01	12,834	—	$0	0	SEC↗
Drappa Jorn	Chief Medical Officer	A Award deriv	2024-07-01	2024-07-01	171,122	—	$0	171,122	SEC↗
Drappa Jorn	Chief Medical Officer	D To issuer deriv	2024-07-01	2024-07-01	171,122	—	$0	0	SEC↗
Drappa Jorn	Chief Medical Officer	A Award deriv	2024-07-01	2024-07-01	85,561	—	$0	85,561	SEC↗
Drappa Jorn	Chief Medical Officer	D To issuer deriv	2024-07-01	2024-07-01	85,561	—	$0	0	SEC↗
Drappa Jorn	Chief Medical Officer	A Award deriv	2024-07-01	2024-07-01	5,347	—	$0	5,347	SEC↗
Drappa Jorn	Chief Medical Officer	D To issuer deriv	2024-07-01	2024-07-01	5,347	—	$0	0	SEC↗
Drappa Jorn	Chief Medical Officer	A Award deriv	2024-07-01	2024-07-01	64,171	—	$0	64,171	SEC↗
Drappa Jorn	Chief Medical Officer	D To issuer deriv	2024-07-01	2024-07-01	64,171	—	$0	0	SEC↗
Drappa Jorn	Chief Medical Officer	A Award deriv	2024-07-01	2024-07-01	70,802	—	$0	70,802	SEC↗
Goldstein David M	Chief Scientific Officer	D To issuer deriv	2024-07-01	2024-07-01	171,122	—	$0	0	SEC↗
Goldstein David M	Chief Scientific Officer	A Award deriv	2024-07-01	2024-07-01	171,122	—	$0	171,122	SEC↗
Goldstein David M	Chief Scientific Officer	D To issuer deriv	2024-07-01	2024-07-01	11,978	—	$0	0	SEC↗
Goldstein David M	Chief Scientific Officer	A Award deriv	2024-07-01	2024-07-01	11,978	—	$0	11,978	SEC↗
Goldstein David M	Chief Scientific Officer	D To issuer deriv	2024-07-01	2024-07-01	30,642	—	$0	0	SEC↗
Goldstein David M	Chief Scientific Officer	A Award deriv	2024-07-01	2024-07-01	42,780	—	$0	42,780	SEC↗
Goldstein David M	Chief Scientific Officer	A Award deriv	2024-07-01	2024-07-01	30,642	—	$0	30,642	SEC↗
Goldstein David M	Chief Scientific Officer	D To issuer deriv	2024-07-01	2024-07-01	206,074	—	$0	0	SEC↗
Goldstein David M	Chief Scientific Officer	A Award deriv	2024-07-01	2024-07-01	206,074	—	$0	206,074	SEC↗
Goldstein David M	Chief Scientific Officer	D To issuer deriv	2024-07-01	2024-07-01	42,780	—	$0	0	SEC↗
Goldstein David M	Chief Scientific Officer	A Award deriv	2024-07-01	2024-07-01	53,475	—	$0	53,475	SEC↗
Goldstein David M	Chief Scientific Officer	D To issuer deriv	2024-07-01	2024-07-01	53,475	—	$0	0	SEC↗
Hardiman Roy C.	Chief Business & Legal Offic	D To issuer deriv	2024-07-01	2024-07-01	30,642	—	$0	0	SEC↗
Hardiman Roy C.	Chief Business & Legal Offic	A Award deriv	2024-07-01	2024-07-01	30,642	—	$0	30,642	SEC↗
Hardiman Roy C.	Chief Business & Legal Offic	D To issuer deriv	2024-07-01	2024-07-01	206,074	—	$0	0	SEC↗
Hardiman Roy C.	Chief Business & Legal Offic	A Award deriv	2024-07-01	2024-07-01	206,074	—	$0	206,074	SEC↗
Hardiman Roy C.	Chief Business & Legal Offic	D To issuer deriv	2024-07-01	2024-07-01	53,475	—	$0	0	SEC↗
Hardiman Roy C.	Chief Business & Legal Offic	A Award deriv	2024-07-01	2024-07-01	53,475	—	$0	53,475	SEC↗
Hardiman Roy C.	Chief Business & Legal Offic	A Award deriv	2024-07-01	2024-07-01	151,871	—	$0	151,871	SEC↗
Hardiman Roy C.	Chief Business & Legal Offic	D To issuer deriv	2024-07-01	2024-07-01	151,871	—	$0	0	SEC↗
Hardiman Roy C.	Chief Business & Legal Offic	A Award deriv	2024-07-01	2024-07-01	42,780	—	$0	42,780	SEC↗
Hardiman Roy C.	Chief Business & Legal Offic	D To issuer deriv	2024-07-01	2024-07-01	42,780	—	$0	0	SEC↗
Hardiman Roy C.	Chief Business & Legal Offic	A Award deriv	2024-07-01	2024-07-01	14,973	—	$0	14,973	SEC↗
Hardiman Roy C.	Chief Business & Legal Offic	D To issuer deriv	2024-07-01	2024-07-01	14,973	—	$0	0	SEC↗
Schroer John R.	Chief Financial Officer	D To issuer deriv	2024-07-01	2024-07-01	17,112	—	$0	0	SEC↗
Schroer John R.	Chief Financial Officer	A Award deriv	2024-07-01	2024-07-01	17,112	—	$0	17,112	SEC↗
Schroer John R.	Chief Financial Officer	D To issuer deriv	2024-07-01	2024-07-01	171,122	—	$0	0	SEC↗
Schroer John R.	Chief Financial Officer	A Award deriv	2024-07-01	2024-07-01	171,122	—	$0	171,122	SEC↗
Schroer John R.	Chief Financial Officer	D To issuer deriv	2024-07-01	2024-07-01	64,171	—	$0	0	SEC↗
Schroer John R.	Chief Financial Officer	A Award deriv	2024-07-01	2024-07-01	64,171	—	$0	64,171	SEC↗
Schroer John R.	Chief Financial Officer	D To issuer deriv	2024-07-01	2024-07-01	12,834	—	$0	0	SEC↗
Schroer John R.	Chief Financial Officer	A Award deriv	2024-07-01	2024-07-01	12,834	—	$0	12,834	SEC↗
Schroer John R.	Chief Financial Officer	D To issuer deriv	2024-07-01	2024-07-01	17,171	—	$0	0	SEC↗
Schroer John R.	Chief Financial Officer	A Award deriv	2024-07-01	2024-07-01	17,171	—	$0	17,171	SEC↗
Schroer John R.	Chief Financial Officer	D To issuer deriv	2024-07-01	2024-07-01	59,516	—	$0	0	SEC↗
Schroer John R.	Chief Financial Officer	A Award deriv	2024-07-01	2024-07-01	59,516	—	$0	59,516	SEC↗
Schroer John R.	Chief Financial Officer	D To issuer deriv	2024-07-01	2024-07-01	55,978	—	$0	0	SEC↗
Schroer John R.	Chief Financial Officer	A Award deriv	2024-07-01	2024-07-01	55,978	—	$0	55,978	SEC↗
Schroer John R.	Chief Financial Officer	D To issuer deriv	2024-07-01	2024-07-01	70,588	—	$0	0	SEC↗
Schroer John R.	Chief Financial Officer	A Award deriv	2024-07-01	2024-07-01	70,588	—	$0	70,588	SEC↗
Klein Sara	General Counsel - Corp Secy	D To issuer deriv	2024-07-01	2024-07-01	38,502	—	$0	0	SEC↗
Klein Sara	General Counsel - Corp Secy	A Award deriv	2024-07-01	2024-07-01	38,502	—	$0	38,502	SEC↗
Klein Sara	General Counsel - Corp Secy	D To issuer deriv	2024-07-01	2024-07-01	8,556	—	$0	0	SEC↗
Klein Sara	General Counsel - Corp Secy	A Award deriv	2024-07-01	2024-07-01	79,572	—	$0	79,572	SEC↗
Klein Sara	General Counsel - Corp Secy	D To issuer deriv	2024-07-01	2024-07-01	79,572	—	$0	0	SEC↗
Klein Sara	General Counsel - Corp Secy	A Award deriv	2024-07-01	2024-07-01	8,556	—	$0	8,556	SEC↗
Klein Sara	General Counsel - Corp Secy	D To issuer deriv	2024-07-01	2024-07-01	73,155	—	$0	0	SEC↗
Klein Sara	General Counsel - Corp Secy	A Award deriv	2024-07-01	2024-07-01	73,155	—	$0	73,155	SEC↗
Klein Sara	General Counsel - Corp Secy	D To issuer deriv	2024-07-01	2024-07-01	42,780	—	$0	0	SEC↗
Klein Sara	General Counsel - Corp Secy	A Award deriv	2024-07-01	2024-07-01	42,780	—	$0	42,780	SEC↗
Klein Sara	General Counsel - Corp Secy	D To issuer deriv	2024-07-01	2024-07-01	21,390	—	$0	0	SEC↗
Klein Sara	General Counsel - Corp Secy	A Award deriv	2024-07-01	2024-07-01	21,390	—	$0	21,390	SEC↗
Klein Sara	General Counsel - Corp Secy	D To issuer deriv	2024-07-01	2024-07-01	11,842	—	$0	0	SEC↗
Klein Sara	General Counsel - Corp Secy	A Award deriv	2024-07-01	2024-07-01	11,842	—	$0	11,842	SEC↗
Richardson Derrick	SVP, People and Culture	A Award deriv	2024-07-01	2024-07-01	4,663	—	$0	4,663	SEC↗
Richardson Derrick	SVP, People and Culture	D To issuer deriv	2024-07-01	2024-07-01	4,663	—	$0	0	SEC↗
Richardson Derrick	SVP, People and Culture	A Award deriv	2024-07-01	2024-07-01	3,208	—	$0	3,208	SEC↗
Richardson Derrick	SVP, People and Culture	D To issuer deriv	2024-07-01	2024-07-01	3,208	—	$0	0	SEC↗
Richardson Derrick	SVP, People and Culture	A Award deriv	2024-07-01	2024-07-01	10,695	—	$0	10,695	SEC↗
Richardson Derrick	SVP, People and Culture	D To issuer deriv	2024-07-01	2024-07-01	10,695	—	$0	0	SEC↗
Richardson Derrick	SVP, People and Culture	A Award deriv	2024-07-01	2024-07-01	19,251	—	$0	19,251	SEC↗
Richardson Derrick	SVP, People and Culture	D To issuer deriv	2024-07-01	2024-07-01	19,251	—	$0	0	SEC↗
Richardson Derrick	SVP, People and Culture	A Award deriv	2024-07-01	2024-07-01	34,224	—	$0	34,224	SEC↗
Richardson Derrick	SVP, People and Culture	D To issuer deriv	2024-07-01	2024-07-01	34,224	—	$0	0	SEC↗
Richardson Derrick	SVP, People and Culture	A Award deriv	2024-07-01	2024-07-01	3,208	—	$0	3,208	SEC↗
Richardson Derrick	SVP, People and Culture	D To issuer deriv	2024-07-01	2024-07-01	3,208	—	$0	0	SEC↗
Richardson Derrick	SVP, People and Culture	A Award deriv	2024-07-01	2024-07-01	29,946	—	$0	29,946	SEC↗
Richardson Derrick	SVP, People and Culture	D To issuer deriv	2024-07-01	2024-07-01	29,946	—	$0	0	SEC↗
Richardson Derrick	SVP, People and Culture	A Award deriv	2024-07-01	2024-07-01	21,390	—	$0	21,390	SEC↗
Richardson Derrick	SVP, People and Culture	D To issuer deriv	2024-07-01	2024-07-01	21,390	—	$0	0	SEC↗
Richardson Derrick	SVP, People and Culture	A Award deriv	2024-07-01	2024-07-01	9,161	—	$0	9,161	SEC↗
Richardson Derrick	SVP, People and Culture	D To issuer deriv	2024-07-01	2024-07-01	9,161	—	$0	0	SEC↗
AKKARAJU SRINIVAS	Director	C Conversion deriv	2024-07-01	2024-07-01	1,703,998	—	$0	0	SEC↗
Machado Patrick	Director	A Award deriv	2024-07-01	2024-07-01	38,000	—	$0	38,000	SEC↗
Machado Patrick	Director	D To issuer deriv	2024-07-01	2024-07-01	38,000	—	$0	0	SEC↗
Srivastava Sapna	Director	D To issuer deriv	2024-07-01	2024-07-01	29,946	—	$0	0	SEC↗
Srivastava Sapna	Director	A Award deriv	2024-07-01	2024-07-01	28,877	—	$0	28,877	SEC↗
Srivastava Sapna	Director	D To issuer deriv	2024-07-01	2024-07-01	28,877	—	$0	0	SEC↗
Srivastava Sapna	Director	A Award deriv	2024-07-01	2024-07-01	29,946	—	$0	29,946	SEC↗
Yao Zhengbin	Director	D To issuer deriv	2024-07-01	2024-07-01	31,016	—	$0	0	SEC↗
Yao Zhengbin	Director	A Award deriv	2024-07-01	2024-07-01	31,016	—	$0	31,016	SEC↗
Yao Zhengbin	Director	D To issuer deriv	2024-07-01	2024-07-01	4,278	—	$0	0	SEC↗
Yao Zhengbin	Director	A Award deriv	2024-07-01	2024-07-01	4,278	—	$0	4,278	SEC↗
Tananbaum James B.	Director, 10% Owner	C Conversion deriv	2024-07-01	2024-07-03	560,076	—	$0	0	SEC↗
Tananbaum James B.	Director, 10% Owner	C Conversion deriv	2024-07-01	2024-07-03	967,567	—	$0	0	SEC↗
Tananbaum James B.	Director, 10% Owner	C Conversion deriv	2024-07-01	2024-07-03	622,344	—	$0	0	SEC↗
Tananbaum James B.	Director, 10% Owner	C Conversion deriv	2024-07-01	2024-07-03	1,122,994	—	$0	0	SEC↗
Tananbaum James B.	Director, 10% Owner	C Conversion deriv	2024-07-01	2024-07-03	481,283	—	$0	0	SEC↗
Tananbaum James B.	Director, 10% Owner	C Conversion deriv	2024-07-01	2024-07-03	560,076	—	$0	0	SEC↗
Tananbaum James B.	Director, 10% Owner	C Conversion deriv	2024-07-01	2024-07-03	681,598	—	$0	0	SEC↗
Tananbaum James B.	Director, 10% Owner	C Conversion deriv	2024-07-01	2024-07-03	1,703,998	—	$0	0	SEC↗
Tananbaum James B.	Director, 10% Owner	C Conversion deriv	2024-07-01	2024-07-03	681,598	—	$0	0	SEC↗
Tananbaum James B.	Director, 10% Owner	C Conversion deriv	2024-07-01	2024-07-03	1,022,398	—	$0	0	SEC↗
Tananbaum James B.	Director, 10% Owner	C Conversion deriv	2024-07-01	2024-07-03	311,172	—	$0	0	SEC↗
Tananbaum James B.	Director, 10% Owner	C Conversion deriv	2024-07-01	2024-07-03	311,172	—	$0	0	SEC↗
Tananbaum James B.	Director, 10% Owner	C Conversion deriv	2024-07-01	2024-07-03	311,172	—	$0	0	SEC↗
Tananbaum James B.	Director, 10% Owner	C Conversion deriv	2024-07-01	2024-07-03	194,459	—	$0	0	SEC↗
Tananbaum James B.	Director, 10% Owner	C Conversion deriv	2024-07-01	2024-07-03	1,944,577	—	$0	0	SEC↗
Foresite Capital Opportunity M	10% Owner	C Conversion deriv	2024-07-01	2024-07-03	1,944,577	—	$0	0	SEC↗
Foresite Capital Opportunity M	10% Owner	C Conversion deriv	2024-07-01	2024-07-03	194,459	—	$0	0	SEC↗
Foresite Capital Opportunity M	10% Owner	C Conversion deriv	2024-07-01	2024-07-03	1,122,994	—	$0	0	SEC↗
Foresite Capital Opportunity M	10% Owner	C Conversion deriv	2024-07-01	2024-07-03	560,076	—	$0	0	SEC↗
Foresite Capital Opportunity M	10% Owner	C Conversion deriv	2024-07-01	2024-07-03	560,076	—	$0	0	SEC↗
Foresite Capital Opportunity M	10% Owner	C Conversion deriv	2024-07-01	2024-07-03	967,567	—	$0	0	SEC↗
Foresite Capital Opportunity M	10% Owner	C Conversion deriv	2024-07-01	2024-07-03	622,344	—	$0	0	SEC↗
Foresite Capital Opportunity M	10% Owner	C Conversion deriv	2024-07-01	2024-07-03	311,172	—	$0	0	SEC↗